We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
-$1.38M
Cap. Flow
+$20.5M
Cap. Flow %
1.94%
Top 10 Hldgs %
7.1%
Holding
774
New
159
Increased
222
Reduced
220
Closed
120

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$5.67M
2
SOFI icon
SoFi Technologies
SOFI
+$5.22M
3
TRU icon
TransUnion
TRU
+$4.01M
4
EXPE icon
Expedia Group
EXPE
+$3.93M
5
CNMD icon
CONMED
CNMD
+$3.78M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$7.81M
2
SWK icon
Stanley Black & Decker
SWK
+$5.62M
3
KMX icon
CarMax
KMX
+$4.41M
4
SG icon
Sweetgreen
SG
+$4.23M
5
MU icon
Micron Technology
MU
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Healthcare 19.51%
3 Industrials 14.23%
4 Consumer Discretionary 11.24%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
651
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$51K ﹤0.01%
22,387
– –
OPRT icon
652
Oportun Financial
OPRT
$262M
$44.7K ﹤0.01%
15,409
-13,862
-47% -$42K
KOD icon
653
Kodiak Sciences
KOD
$2.62B
$38.3K ﹤0.01%
+16,310
New +$55.3K
PBYI icon
654
Puma Biotechnology
PBYI
$407M
$36.3K ﹤0.01%
+11,131
New +$48.9K
ACMR icon
655
ACM Research
ACMR
$5.53B
– –
-7,157
Closed -$209K
AES icon
656
AES
AES
$10.6B
– –
-78,600
Closed -$1.41M
AMLX icon
657
Amylyx Pharmaceuticals
AMLX
$2.17B
– –
-166,896
Closed -$474K
ANGO icon
658
AngioDynamics
ANGO
$565M
– –
-33,292
Closed -$195K
ANNX icon
659
Annexon
ANNX
$841M
– –
-39,505
Closed -$283K
APGE icon
660
Apogee Therapeutics
APGE
$10.2B
– –
-9,629
Closed -$640K
ARVN icon
661
Arvinas
ARVN
$530M
– –
-56,134
Closed -$2.32M
ASTE icon
662
Astec Industries
ASTE
$1.29B
– –
-12,548
Closed -$548K
JBIO
663
Jade Biosciences
JBIO
$1.21B
– –
-362
Closed -$375K
AWR icon
664
American States Water
AWR
$3.37B
– –
-5,553
Closed -$401K
AX icon
665
Axos Financial
AX
$5.45B
– –
-9,450
Closed -$511K
BEAM icon
666
Beam Therapeutics
BEAM
$2.58B
– –
-55,649
Closed -$1.84M
BKU icon
667
Bankunited
BKU
$3.36B
– –
-9,846
Closed -$276K
BPMC
668
DELISTED
Blueprint Medicines
BPMC
– –
-15,129
Closed -$1.44M
BRKR icon
669
Bruker
BRKR
$9.14B
– –
-15,073
Closed -$1.42M
BTU icon
670
Peabody Energy
BTU
$2.81B
– –
-55,028
Closed -$1.33M
CCRN
671
DELISTED
Cross Country Healthcare
CCRN
– –
-21,937
Closed -$411K
CDNS icon
672
Cadence Design Systems
CDNS
$93.4B
– –
-2,733
Closed -$851K
CFFN icon
673
Capitol Federal Financial
CFFN
$1.07B
– –
-25,587
Closed -$152K
CLNE icon
674
Clean Energy Fuels
CLNE
$432M
– –
-195,128
Closed -$523K
CMA
675
DELISTED
Comerica
CMA
– –
-7,117
Closed -$391K
25 26
27
28 29

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q2 2024 Portfolio in Review

As of Q2 2024, PDT Partners held 774 positions worth $1.06B, down 0.13% from $1.06B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

PDT Partners's Q2 2024 filing shows 159 new, 222 increased, 220 reduced and 120 closed positions. Its largest new stake was SoFi Technologies: 740,850 shares worth $4.9M. The largest sale was Ferrari, an estimated $7.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • PDT Partners's largest Q2 2024 buy was SoFi Technologies: 740,850 shares worth $4.9M.
  • PDT Partners added most to 10x Genomics in Q2 2024, an estimated $5.67M increase.
  • PDT Partners's biggest Q2 2024 reduction was Ferrari, cutting an estimated $7.81M.
  • PDT Partners fully exited CarMax in Q2 2024, selling an estimated $4.41M.
  • PDT Partners's ten largest holdings make up 7.1% of its $1.06B portfolio in Q2 2024.
  • PDT Partners opened 159 new positions and closed 120 in Q2 2024.
  • PDT Partners's portfolio value fell 0.13% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.